Actively Recruiting

Age: 18Years - 80Years
All Genders
ID03233087

Diagnosis and Prognosis for Aortic Aneurysm and Dissection in Anzhen Registry Study

Led by Beijing Institute of Heart, Lung and Blood Vessel Diseases · Updated on 2024-06-27

1500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Lead Sponsor

B

Beijing Luhe Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate biomarkers for the diagnosis and prognosis of aortic aneurysm and aortic dissection. It includes a discovery phase with age- and sex-matched case-control groups for various conditions including aortic dissection, acute myocardial infarction, pulmonary embolism, aortic aneurysm without dissection, and healthy controls. The study also follows patients with confirmed aortic aneurysm and dissection to assess outcomes like mortality. The study has two parts: a retrospective diagnosis phase and a prospective prognosis phase. Patients are enrolled based on clinical suspicion or confirmed diagnosis. Biomarker levels are categorized into thirds for analysis. The primary focus is on all-cause mortality and in-hospital mortality as outcome measures collected from medical records and follow-up visits over an average of 6 months to 2-4 years. Participants undergo medical record reviews and follow-up visits to collect data on diagnosis and prognosis. Researchers monitor survival outcomes and biomarker levels over time. The study involves adults aged 18 to 80 years and tracks patient health status through medical documentation and follow-ups to better understand disease progression and outcomes.

CONDITIONS

Brief Title

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients referred to surgical service for evaluation and management of aortic dissection (retrospective)
  • Patients with initial suspicion of acute aortic dissection enrolled prospectively
  • Age between 18 and 80 years
  • Both male and female participants
Not Eligible

You will not qualify if you...

  • Patients who received blood transfusions (packed red blood cells, whole blood, or platelets) less than 10 days before sample collection (retrospective)
  • Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer (retrospective)
  • Patients admitted for checkups after surgery (retrospective)
  • Patients with little or no suspicion of life-threatening disease (prospective)
  • Patients with confirmed acute myocardial infarction, angina, or pulmonary embolism (prospective)
  • Patients with symptoms clearly unrelated to aortic dissection, such as pleurisy, pneumonia, or acute abdominal diseases (prospective)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 6 months

Participants with suspicion of aortic dissection undergo diagnostic assessments and biomarker sample collection to determine diagnosis.

1 visit (in-person) for sample collection and medical record review

Long-term Monitoring

Duration - 2 to 4 years after discharge

Participants are followed for prognosis assessment through medical record review and follow-up visits to evaluate outcomes such as mortality.

Follow-up visits as scheduled over 2 to 4 years

Trial Site Locations

Total: 1 location

1

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China, 100029

Actively Recruiting

Loading map...

Research Team

Y

Yuan Wang, PhD

X

Xue Wang, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Evaluation of the Rapidlink Device for Use in Repair or Repl...

Aortic Aneurysm

Actively Recruiting

23 locations

AI-CARE: Artificial Intelligence for Cardiovascular Analysis...

Aortic Aneurysm

Actively Recruiting

3 locations

Analysis of Individual Activity at the Time of Aortic Ruptur...

Aortic Aneurysm

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here